Navigation Links
Wyeth Presents Phase 3 Data for Pristiq, an Investigational,Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats

thought to play an important role in the brain to regulate body temperature and, during menopause may become imbalanced leading to hot flashes and night sweats.

Wyeth filed a New Drug Application June 23, 2006, with the FDA for Pristiq for the treatment of moderate-to-severe vasomotor symptoms associated with menopause. If approved, Wyeth anticipates that Pristiq will be the first and only non-hormonal medication indicated for the treatment of moderate-to-severe vasomotor symptoms associated with menopause in the United States. Based on review of publicly disclosed studies, Pristiq is the first non-hormonal therapy to be studied in long-term (six and 12 months), placebo-controlled trials. Pristiq is also under review for the treatment of major depressive disorder, and Wyeth received an approvable letter from the FDA on January 23, 2007, for this indication.

About Wyeth Pharmaceuticals

Wyeth Pharmaceuticals, a division of Wyeth, has leading products in the areas of women's health care, infectious disease, gastrointestinal health, central nervous system, inflammation, transplantation, hemophilia, oncology, vaccines and nutritional products.

Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing and marketing of pharmaceuticals, vaccines, biotechnology products and non-prescription medicines that improve the quality of life for people worldwide. The Company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.

The statements in this press release that are not historical facts are forward-looking statements based on current expectations of future events and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. In particular, the statements in this press release regarding clinical data and/o
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Progenics and Wyeth Announce Positive Results from Three-Month Clinical-Extension Study of Subcutaneous Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Advanced Illness
2. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
3. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
4. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
5. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
6. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
7. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
8. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
9. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
10. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
11. DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein
Post Your Comments:
(Date:5/22/2015)...  The Mesothelioma Victims Center is incredibly passionate ... the best possible compensation, and they are also extremely ... cancer caused by exposure to asbestos or their ... treatment options such as a recent possible medical breakthrough. ... Center anytime at 866-714-6466. http://MesotheliomaVictimsCenter.Com ...
(Date:5/22/2015)... , May 22, 2015 Research and Markets ... addition of the "Latest Regulations on Pharmaceutical ... to their offering. This is first ... a guidance on international multi-center clinical trials of ... has begun to be implemented on March 1, ...
(Date:5/22/2015)... May 22, 2015 AcelRx Pharmaceuticals, Inc. (Nasdaq: ... the development and commercialization of innovative therapies for the ... interim chief executive officer Howie Rosen will ... financial officer Tim Morris will be presenting ... two presentations are as follows: Jefferies 2015 ...
Breaking Medicine Technology:Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 2Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 52015 Regulations on Pharmaceutical International Multi-Center Clinical Trials in China 2AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences In June 2
... , , , , ... Cardium Therapeutics (NYSE Amex: CXM ) today announced that ... completed their initial 12-week evaluation period and that it plans to ... , , (Logo: http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO ) , , ...
... TEL AVIV, Israel and SOUTHAMPTON, Pennsylvania, ... patient monitors, cardiac,catheterization and electrophysiology systems, announced today ... has awarded Mennen Medical,the 2009 European Patient Monitoring ... This prestigious award is bestowed ...
Cached Medicine Technology:Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study 2Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study 3Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study 4Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study 5Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study 6Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study 7Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study 8Mennen Medical Receives Frost & Sullivan 2009 European Patient Monitoring Technology Leadership Award 2Mennen Medical Receives Frost & Sullivan 2009 European Patient Monitoring Technology Leadership Award 3
(Date:5/22/2015)... DC (PRWEB) May 22, 2015 Family, ... University Hospital’s world-renowned surgical oncologist, Dr. LaSalle D. Leffall, ... , The luncheon began after Grand Rounds in the ... Leffall, waited anxiously outside the auditorium, trying to keep ... him, but if he sees me, he’ll know something ...
(Date:5/22/2015)... Massachusetts (PRWEB) May 22, 2015 ... is a difficult process. Historically providers have not ... by payers. Starting in 2015, Medicare has paved ... coordination activities. Thanks to the launch of ... providers and health systems using the platform will ...
(Date:5/22/2015)... WA (PRWEB) May 22, 2015 According to ... of all generations are equally as likely to worry about ... Millennials, 75% Gen X, 77% Boomers, 69% Silent Generation), which ... agree they are scared of aging, particularly Millennials (47%), Gen ... by Harris Poll in April, 2015 among more than 2,000 ...
(Date:5/22/2015)... Coco Libre, the Official Coconut Water of Zappos.com Bay ... 104th running of the race. On Sunday, May 17, 2015, ... in one hour—one person about every 10 seconds. , ... the heart of the Bay Area, so unique, whimsical and ... finish line only made sense,” said Jennifer Goodrum, Coco Libre ...
(Date:5/22/2015)... According to Berks and Beyond , Pennsylvania ... totaling almost 2,500 confirmed drug deaths, as reported on May ... 2,489 deaths stemming from legal and illegal drug use in ... every day to fatal overdoses or other drug related deaths. ... of the most rife with drug related deaths. The city, ...
Breaking Medicine News(10 mins):Health News:Colleagues Surprise Dr. LaSalle Leffall with 85th Birthday Celebration 2Health News:Oculus Health Care Coordination Platform Officially Launched 2Health News:Oculus Health Care Coordination Platform Officially Launched 3Health News:Oculus Health Care Coordination Platform Officially Launched 4Health News:New Study Reveals America’s Fear of Aging 2Health News:New Study Reveals America’s Fear of Aging 3Health News:Coco Libre Ice Luge Sets New World Record at Bay to Breakers 2Health News:Philadelphia Ranks Among the Tops Cities in Penn. for Drug Deaths 2
... Every woman could use,a little pampering now and then. Think ... the Pennsylvania Breast Cancer Coalition,(PBCC) and Doneckers of Ephrata take ... tell us in 250 words or less why your mom, ... family or,community, and you and your mom could be in ...
... Reject Oxygen Funding Reductions,which could "Jeopardize Care" and ... Letter Draws Widespread Support Among Home Oxygen Community, ... Quality,Respiratory Care (CQRC) -- a coalition of the ... provide care and services to,approximately 650,000 chronically ill ...
... could reduce access to necessary medications for ... thousands of Americans, INDIANAPOLIS, ... its strong support for mental health parity,-- the principle that insurers should ... over the way the,parity legislation in the U.S. House (HR 1424) seeks ...
... Longs Drug,Stores Corporation (NYSE: LDG ) ... fourth quarter ended January 31, 2008, a,14-week period, ... including a,$1.1 million after-tax net gain related to ... continuing operations for the fourth quarter,ended January 25, ...
... - ... management segment revenue grew 33 percent - Revenue mix shifted to 44 percent health management ... ... and generated 24 new health, management requests for proposal (RFPs), compared to four commitments and ...
... of the first, study finds , , WEDNESDAY, March 5 (HealthDay ... may be more likely to become pregnant again within two ... of Medicine study. , The study followed 269 predominately black ... care at five community sites. One or two years after ...
Cached Medicine News:Health News:The Pennsylvania Breast Cancer Coalition Announces Last Chance to Enter 'Makeover for Mom' Contest 2Health News:Home Oxygen Community Applauds Senator Blanche Lincoln for Leading Bi-Partisan Effort to Formally Oppose Proposed Cuts to Medicare's Home Oxygen Benefit 2Health News:Mental Health Parity Laudable, But House Legislation Would Put Medicaid Patients at Risk, Lilly Says 2Health News:Mental Health Parity Laudable, But House Legislation Would Put Medicaid Patients at Risk, Lilly Says 3Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 2Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 3Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 4Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 5Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 6Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 7Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 8Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 9Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 10Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 11Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 12Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 13Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 14Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 15Health News:HealthFitness Announces 2007 Fourth Quarter and Full-Year Results 2Health News:HealthFitness Announces 2007 Fourth Quarter and Full-Year Results 3Health News:HealthFitness Announces 2007 Fourth Quarter and Full-Year Results 4Health News:HealthFitness Announces 2007 Fourth Quarter and Full-Year Results 5Health News:HealthFitness Announces 2007 Fourth Quarter and Full-Year Results 6Health News:HealthFitness Announces 2007 Fourth Quarter and Full-Year Results 7Health News:HealthFitness Announces 2007 Fourth Quarter and Full-Year Results 8Health News:HealthFitness Announces 2007 Fourth Quarter and Full-Year Results 9Health News:HealthFitness Announces 2007 Fourth Quarter and Full-Year Results 10Health News:HealthFitness Announces 2007 Fourth Quarter and Full-Year Results 11Health News:Depression Raised Risk of Subsequent Pregnancies Among Black Teen Moms 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: